Related Experiment Videos

Haemophilus influenzae b-vaccination: the urgency for timely vaccination

R von Kries1, O Böhm, A Windfuhr

  • 1Institute of Social Paediatrics, Kinderzentrum München, Germany.

Insights

Suboptimal Haemophilus influenzae type b (Hib) vaccination schedules significantly increase infection risk in children. Completing Hib vaccinations on time, including boosters, is crucial for effective protection against invasive Hib disease.

Area of Science:

  • Pediatric Infectious Diseases
  • Vaccinology
  • Epidemiology

Background:

  • Systemic Haemophilus influenzae type b (Hib) infections pose a significant risk to young children.
  • Recent data indicate an increase in Hib cases among vaccinated children, suggesting potential issues with vaccination timeliness or completeness.

Purpose of the Study:

  • To investigate the association between age-related suboptimal vaccination status and the risk of systemic Hib infections in children.
  • To quantify the increased risk of Hib infection due to incomplete or delayed vaccination schedules.

Main Methods:

  • A case-control study was conducted in West Germany between July 1992 and August 1994.
  • Cases of systemic Hib infections were identified via active hospital surveillance.
  • Six age-matched population controls were recruited per case; only vaccinated individuals were included.

Main Results:

  • Suboptimal vaccination for age was found to increase the risk of systemic Hib infections by a factor of 4.74 (95% CI: 2.17-10.34).
  • After adjusting for confounders, the odds ratio for suboptimal vaccination remained significant at 4.39 (95% CI: 1.74-11.07).
  • The risk was not associated with the specific vaccine type used; lack of a booster vaccination in children over 18 months showed a particularly high risk.

Conclusions:

  • On-schedule and complete Haemophilus influenzae type b (Hib) vaccinations are essential for the effectiveness of vaccination programs.
  • Booster vaccinations between 12 and 18 months are critical when using PRP-D, HbOC, and OMP vaccines for primary immunization.
Abstract

Related Concept Videos